| Dr Luisa Vanessa Marcial, MD | |
|
Ext. Hnas Davila Marginal Carr. Pr #2, Edificio 1955 Suite G-1, Bayamon, PR 00959 | |
| (787) 966-7500 | |
| (787) 966-7505 |
| Full Name | Dr Luisa Vanessa Marcial |
|---|---|
| Gender | Female |
| Speciality | Radiation Oncology |
| Experience | 42 Years |
| Location | Ext. Hnas Davila Marginal Carr. Pr #2, Bayamon, Puerto Rico |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326181462 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0001X | Radiology - Radiation Oncology | 8281 (Puerto Rico) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Auxilio Mutuo Hospital | Hato rey, PR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Caribbean Imaging And Radiation Treatment Center Inc | 4486782307 | 14 |
| Centro De Radioterapia Auxilio Mutuo Inc | 2365507068 | 6 |
| Precise Radiation Oncology Center Psc | 2961685482 | 4 |
News Archive
A world-first study in today's New England Journal of Medicine heralds the efficacy of a targeted combination drug therapy after reporting major declines in the risk of disease progression and death in people with metastatic melanoma.
Treatment options for liver cancer are often limited and almost exclusively involve transplantation if possible, or local chemoembolization and radiofrequency ablation.
Use of a special catheter that sucks out, or aspirates, bits of plaque and blood clot that break loose during percutaneous coronary intervention (PCI) significantly enhances blood flow deep in the heart muscle in patients who are experiencing a heart attack, according to a recently published study.
PanGenex Corporation announced that due to promising pre-clinical results from its clinical trial at the Cardiovascular Institute of the South (http://www.cardio.com/site1.php), the Company will extend its trial to two additional sites.
› Verified 5 days ago
| Entity Name | Centro De Radioterapia Auxilio Mutuo Inc |
|---|---|
| Entity Type | Part B Supplier - Radiation Therapy Center |
| Entity Identifiers | NPI Number: 1154379253 PECOS PAC ID: 2365507068 Enrollment ID: O20090212000390 |
News Archive
A world-first study in today's New England Journal of Medicine heralds the efficacy of a targeted combination drug therapy after reporting major declines in the risk of disease progression and death in people with metastatic melanoma.
Treatment options for liver cancer are often limited and almost exclusively involve transplantation if possible, or local chemoembolization and radiofrequency ablation.
Use of a special catheter that sucks out, or aspirates, bits of plaque and blood clot that break loose during percutaneous coronary intervention (PCI) significantly enhances blood flow deep in the heart muscle in patients who are experiencing a heart attack, according to a recently published study.
PanGenex Corporation announced that due to promising pre-clinical results from its clinical trial at the Cardiovascular Institute of the South (http://www.cardio.com/site1.php), the Company will extend its trial to two additional sites.
› Verified 5 days ago
| Entity Name | Caribbean Imaging And Radiation Treatment Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033183603 PECOS PAC ID: 4486782307 Enrollment ID: O20100513000145 |
News Archive
A world-first study in today's New England Journal of Medicine heralds the efficacy of a targeted combination drug therapy after reporting major declines in the risk of disease progression and death in people with metastatic melanoma.
Treatment options for liver cancer are often limited and almost exclusively involve transplantation if possible, or local chemoembolization and radiofrequency ablation.
Use of a special catheter that sucks out, or aspirates, bits of plaque and blood clot that break loose during percutaneous coronary intervention (PCI) significantly enhances blood flow deep in the heart muscle in patients who are experiencing a heart attack, according to a recently published study.
PanGenex Corporation announced that due to promising pre-clinical results from its clinical trial at the Cardiovascular Institute of the South (http://www.cardio.com/site1.php), the Company will extend its trial to two additional sites.
› Verified 5 days ago
| Entity Name | Precise Radiation Oncology Center Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033426614 PECOS PAC ID: 2961685482 Enrollment ID: O20110322000121 |
News Archive
A world-first study in today's New England Journal of Medicine heralds the efficacy of a targeted combination drug therapy after reporting major declines in the risk of disease progression and death in people with metastatic melanoma.
Treatment options for liver cancer are often limited and almost exclusively involve transplantation if possible, or local chemoembolization and radiofrequency ablation.
Use of a special catheter that sucks out, or aspirates, bits of plaque and blood clot that break loose during percutaneous coronary intervention (PCI) significantly enhances blood flow deep in the heart muscle in patients who are experiencing a heart attack, according to a recently published study.
PanGenex Corporation announced that due to promising pre-clinical results from its clinical trial at the Cardiovascular Institute of the South (http://www.cardio.com/site1.php), the Company will extend its trial to two additional sites.
› Verified 5 days ago
| Entity Name | Precise Radiosurgery Solutions Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437779907 PECOS PAC ID: 7618393133 Enrollment ID: O20200814000875 |
News Archive
A world-first study in today's New England Journal of Medicine heralds the efficacy of a targeted combination drug therapy after reporting major declines in the risk of disease progression and death in people with metastatic melanoma.
Treatment options for liver cancer are often limited and almost exclusively involve transplantation if possible, or local chemoembolization and radiofrequency ablation.
Use of a special catheter that sucks out, or aspirates, bits of plaque and blood clot that break loose during percutaneous coronary intervention (PCI) significantly enhances blood flow deep in the heart muscle in patients who are experiencing a heart attack, according to a recently published study.
PanGenex Corporation announced that due to promising pre-clinical results from its clinical trial at the Cardiovascular Institute of the South (http://www.cardio.com/site1.php), the Company will extend its trial to two additional sites.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Luisa Vanessa Marcial, MD Po Box 1589, Bayamon, PR 00960-1589 Ph: (787) 966-7500 | Dr Luisa Vanessa Marcial, MD Ext. Hnas Davila Marginal Carr. Pr #2, Edificio 1955 Suite G-1, Bayamon, PR 00959 Ph: (787) 966-7500 |
News Archive
A world-first study in today's New England Journal of Medicine heralds the efficacy of a targeted combination drug therapy after reporting major declines in the risk of disease progression and death in people with metastatic melanoma.
Treatment options for liver cancer are often limited and almost exclusively involve transplantation if possible, or local chemoembolization and radiofrequency ablation.
Use of a special catheter that sucks out, or aspirates, bits of plaque and blood clot that break loose during percutaneous coronary intervention (PCI) significantly enhances blood flow deep in the heart muscle in patients who are experiencing a heart attack, according to a recently published study.
PanGenex Corporation announced that due to promising pre-clinical results from its clinical trial at the Cardiovascular Institute of the South (http://www.cardio.com/site1.php), the Company will extend its trial to two additional sites.
› Verified 5 days ago
Dr. Robert Rivera, Radiology Medicare: Accepting Medicare Assignments Practice Location: 1815 Road # 2 Km 11.7, Ct Radiology Complex Bldg, Bayamon, PR 00959 Phone: 787-780-9069 Fax: 787-780-2121 | |
Dr. Pedro E Diaz Ortiz, Radiology Medicare: Accepting Medicare Assignments Practice Location: Gallardo Towers, 201, Bayamon, PR 00961 Phone: 787-787-8029 Fax: 787-787-8029 | |
Francisco Jose Orobitg Brenes, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: Ct Radiology Complex, 1815 Carr 2, Bayamon, PR 00959 Phone: 787-780-9069 Fax: 787-778-4938 | |
Dr. Carlos Balsalobre Alonso, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1815 Road No 2 Km 11.7, Ct Radiology Complex, Bayamon, PR 00959 Phone: 787-780-9069 Fax: 787-780-2121 | |
Dr. Alberto Cerra Franco, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: Ext. Hnas Davila. Marginal Pr #2. Esq 3b, Edificio 1955. Suite G1, Bayamon, PR 00959 Phone: 787-966-7500 | |
Rafael Andres Vicens Rodriguez, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1710 Carr 2 # Int167, Condominio Gallardo Towers Suite 101, Bayamon, PR 00961 Phone: 787-785-8034 Fax: 787-787-8029 |